Next Article in Journal
Bevacizumab for Glioblastoma—A Promising Drug or Not?
Next Article in Special Issue
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment
Previous Article in Journal / Special Issue
The Protective Role of Vitamin D Signaling in Non-Melanoma Skin Cancer
 
 
Discussion

Article Versions Notes

Cancers 2013, 5(4), 1439-1455; https://doi.org/10.3390/cancers5041439
Action Date Notes Link
article pdf uploaded. 5 November 2013 10:46 CET Version of Record https://www.mdpi.com/2072-6694/5/4/1439/pdf
article xml file uploaded 6 January 2014 11:09 CET Original file https://www.mdpi.com/2072-6694/5/4/1439/xml
article html file updated 6 January 2014 11:09 CET Original file -
article html file updated 21 March 2019 07:08 CET Update -
article html file updated 7 May 2019 22:30 CEST Update -
article html file updated 6 February 2020 05:21 CET Update https://www.mdpi.com/2072-6694/5/4/1439/html
Back to TopTop